Palatin Technologies Is A Biopharmaceutical Company Based In Cranburynew Jerseythe Company Focuses On Developing Receptor Specific Therapeutics Aimed At Treating Inflammatory And Autoimmune Diseasesby Leveraging The Melanocortin Receptor Systempalatin Seeks To Address Harmful Inflammation And Improve Conditions With Significant Unmet Medical Needsparticularly In Ocularmetabolicand Autoimmune Disorders Palatin S Product Pipeline Includes Vyleesia Bremelanotide Which Is Marketed For Hypoactive Sexual Desire Disorderand Several Candidates In Various Stages Of Developmentthese Include Pl9643 For Dry Eye Diseasecurrently In Phase 3 Trialsand Pl8177 For Inflammatory Bowel Diseaseswhich Is In Phase 2 Studiesthe Company Also Explores Combination Therapies To Enhance Treatment Efficacypalatin Collaborates With Partners Like Cosette Pharmaceuticals For Commercialization And Relies On Contract Manufacturing Organizations For Production
No conferences found for this company.
| Company Name | Palatin Technologies Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
